Evan Choi, MD
Cardiovascular Disease · Flushing, NYNPI 1023351855
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,685 of the $2,495 with a category attached, or 67.5%. It is spread thinly across 19 manufacturers, the largest accounting for just 23.8%.
Across 56 payments — averaging $44.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$594
- Medtronic$265
- Astellas Pharma US Inc$231
- Amgen$216
- Merck$163
- Inari Medical, Inc.$137
- plus $888 from 13 others
What the payments were for
- Food & beverage$1,68568%
- Education$81032%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 5 | $594 |
| Medtronic(2 entities) | 2 | $265 |
| Astellas Pharma US Inc | 3 | $231 |
| Amgen | 6 | $216 |
| Merck | 8 | $163 |
| Inari Medical, Inc. | 2 | $137 |
| United Therapeutics Corporation | 4 | $123 |
| Impulse Dynamics (USA) Inc. | 1 | $121 |
| AstraZeneca | 1 | $103 |
| Daiichi Sankyo Inc. | 4 | $102 |
| Novo Nordisk | 4 | $98 |
| Boehringer Ingelheim | 3 | $66 |
| E.r. Squibb & Sons, L.L.C. | 3 | $65 |
| Boston Scientific | 3 | $57 |
| Novartis | 2 | $53 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $35 |
| Lilly USA, LLC | 1 | $24 |
| Scpharmaceuticals Inc. | 1 | $22 |
| Lantheus Medical Imaging, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ensite Cardiac Mapping System$440
- OPTIMIZER$241
- FLOWTRIEVER CATHETER, S$239
- OSTEOCOOL RF ABLATION SYSTEM$163
- ENSITE PRECISION$139
- Repatha$125
- BRILINTA$103
- Resolute$103
How this compares
$2,495 in reported general payments places this provider in the 55th percentile of 2,302 cardiovascular disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $19,005 |
| Metoprolol Succinate | 30 | $788 |
| Rosuvastatin Calcium | 39 | $543 |
| Atorvastatin Calcium | 45 | $484 |
| Ezetimibe | 13 | $406 |
| Nifedipine ErNifedipine | 13 | $284 |
| Amlodipine Besylate | 34 | $230 |
| Losartan Potassium | 23 | $174 |
| Lisinopril | 22 | $108 |
| Carvedilol | 18 | $91 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Flushing
- Roger HajjarNew York$5.2M
- Szilard VorosStony Brook$3.7M
- Gregg StoneNew York$2M
- Augustin DelagoAlbany$1.8M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Luigi di BiaseBronx$978K
- Vijay IyerAmherst$855K
- Megha PrasadNew York$813K
- Ronald DagostinoLake Success$782K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.